drugset
drugset / Trial / NCT03092635

AGE Levels in ER+ Metastatic Breast Cancer Patients Receiving Endocrine Therapy

NCT03092635 ↗

Phase 1 Terminated 9 enrolled Medical University of South Carolina
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to look at the effects that the study drug (OPC) has on AGE levels in patients with ER+ metastatic breast cancer.

Timeline

Start
2017-06-06
Primary completion
2021-11-10
Completion
2022-04-22

Outcome

Outcome not reported

Stopped: “Original principal investigator departed institution and concluded the study upon departure.”

Drugs

EvaluationDrugModalityDoseRoute
Subject OPC Unknown — Oral

Indications

breast cancer